Press Releases Latest Dec 18, 2024 Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment Press Releases Year None202420232022202120202019201820172016201520142013 Nov 27, 2019 Theratechnologies’ CFO to Attend Piper Jaffray 31st Annual Healthcare Conference in New York City Nov 25, 2019 Theratechnologies Starts Commercialization of New EGRIFTA SV™ in the United States Nov 14, 2019 Theratechnologies’ CFO to Attend Stifel Healthcare Conference in New York City Nov 07, 2019 Trogarzo® Remains Effective Close to a Decade After Treatment Initiation Oct 21, 2019 Theratechnologies Provides Details About R&D Day Webcast Oct 11, 2019 Tesamorelin Study Results On NAFLD Published in Lancet HIV Oct 10, 2019 Canadian Commercial-Stage Biopharmaceutical Company Theratechnologies Announces NASDAQ Listing Oct 08, 2019 Theratechnologies Announces Financial Results for the Third Quarter of 2019 Oct 04, 2019 1.7 Million Dollar Grant Towards Development of Theratechnologies’ Targeted Oncology Platform Oct 03, 2019 New 48-Week Data Presented at IDWeek Show Trogarzo® Remains Safe and Effective First page « Previous page ‹ … Page 16 Page 17 Page 18 Page 19 Current page 20 Page 21 Page 22 Page 23 Page 24 … Next page › Last page » Displaying 191 - 200 of 379
Dec 18, 2024 Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment
Nov 27, 2019 Theratechnologies’ CFO to Attend Piper Jaffray 31st Annual Healthcare Conference in New York City
Oct 10, 2019 Canadian Commercial-Stage Biopharmaceutical Company Theratechnologies Announces NASDAQ Listing
Oct 04, 2019 1.7 Million Dollar Grant Towards Development of Theratechnologies’ Targeted Oncology Platform
